Silence Therapeutics Plc (SLN) has released an update.
Silence Therapeutics plc successfully held its Annual General Meeting where all proposed resolutions were approved by its shareholders. The voting took place via poll on May 17, 2024, reflecting solid shareholder support for the company’s direction and leadership. This event marks a significant milestone for the London-based biotech firm.
For further insights into SLN stock, check out TipRanks’ Stock Analysis page.
